Florida's Medicaid experiment continues to draw attention

NewsGuard 100/100 Score

News outlets report on the state's effort to shift care for Medicaid enrollees to managed care and how this move will impact specific populations such as pregnant women.

The New York Times: In Florida, HMO's Would Treat Medicaid Patients
A crucial experiment in the future of Medicaid is playing out in Florida, where both houses of the Legislature are vying to find ways to drastically cut costs, manage care and reduce waste and fraud. The cuts and changes being sought by the Republican-led Legislature and encouraged by the new Republican governor, Rick Scott, a wealthy former hospital company executive, are deeper than those in many other states (Alvarez, 4/27).

See previous KHN story: Insurers Clash With Health Providers As States Expand Medicaid Managed Care (Galewitz, 4/26).

Health News Florida: Mothers-To-Be To See Medicaid Change
Waddling into the doctor's office at eight months pregnant, two kids in tow, Danielle Johnson fully expected to see her obstetrician. ... Suddenly the receptionist called her name. "I'm sorry, but your insurance has been switched," she said. "Now you're on First Coast, and we don't take (that)." What happened to Johnson is worth a listen, because she lives in Duval County, one of the five test sites for a Medicaid experiment that moves enrollees into HMOs or similar managed-care networks (Davis, 4/27).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment